1
E therapy to either placebo or nothing (the control groups) [21]. Women were recruited in Estonia from 1999?001, and followed by annually mailed questionnaires in 2000?004. Detailed descriptions of the recruitment, inclusion and exclusion criteria, trial treatment, adherence, follow-up and trial outcomes as well as the content of information leaflets and trial questionnaires have been published el
1
Ughly the same level. Table 3 gives the results of the longitudinal analysis in which the same women were followed from one survey to another. There were some differences by the number of follow-ups (how early or late the woman was recruited) as well as by compliance with the surveys (did she skip some of the surveys, group "Intermittent surveys" in Table 3). In the groups with only three or twoTa
1
Evelop and validate a Pregnancy Symptoms Inventory for use by health professionals. Methods: A list of symptoms was generated via expert consultation with health professionals. Focus groups were conducted with pregnant women. The inventory was tested for face validity and piloted for readability and comprehension. For test-re-test reliability, the tool was administered to the same women 2 to 3 day
1
Men's experience of the menopause. Br J Obstet Gynaecol 1996, 103:1025?028. Mitchell ES, Woods NF: Symptom experiences of midlife women: observations from the Seattle midlife women's health study. Maturitas 1996, 25:1?0. Jokinen K, Rautava P, M inen J, Ojanlatva A, Sundell J, Helenius H: Experience of climacteric symptoms among 42?6 and 52?6-year-old women. Maturitas 2003, 46:199?05. Col NF, Guthr
1
Men's experience of the menopause. Br J Obstet Gynaecol 1996, 103:1025?028. Mitchell ES, Woods NF: Symptom experiences of midlife women: observations from the Seattle midlife women's health study. Maturitas 1996, 25:1?0. Jokinen K, Rautava P, M inen J, Ojanlatva A, Sundell J, Helenius H: Experience of climacteric symptoms among 42?6 and 52?6-year-old women. Maturitas 2003, 46:199?05. Col NF, Guthr
1
Men's experience of the menopause. Br J Obstet Gynaecol 1996, 103:1025?028. Mitchell ES, Woods NF: Symptom experiences of midlife women: observations from the Seattle midlife women's health study. Maturitas 1996, 25:1?0. Jokinen K, Rautava P, M inen J, Ojanlatva A, Sundell J, Helenius H: Experience of climacteric symptoms among 42?6 and 52?6-year-old women. Maturitas 2003, 46:199?05. Col NF, Guthr
1
Women. Women (aged 16 to 65 years) attending two public hospitals in Erbil city for reproductive health problems were included in the study. The study was conducted between 1st of October 2009 and 30th of March 2011. Each woman was seen only once. Intimate partner violence was assessed by administering a modified version of the World Health Organization's domestic violence questionnaire through di
1
Ps were very similar by the studied background characteristics. Table 2 gives the prevalence of vasomotor symptoms according to a cross-sectional analysis. At the time of recruitment, about two thirds of the women reported vasomotor symptoms, and about a half regarded them as bothersome. In the survey a year later, less (53 ) of women reported vasomotor symptoms and a third found them bothersome.